Risk factors for pancreatitis after endoscopic retrograde cholangiopancreatography in children

YANG Lu; FU Yan; SUN Zheng-Hao; ZHOU Jia; TANG Juan; NI Jing

doi:10.7499/j.issn.1008-8830.2402047

PDF(557 KB)

Chinese Journal of Contemporary Pediatrics ›› 2024, Vol. 26 ›› Issue (7) : 690-694. DOI: 10.7499/j.issn.1008-8830.2402047

CLINICAL RESEARCH

Risk factors for pancreatitis after endoscopic retrograde cholangiopancreatography in children

YANG Lu, FU Yan, SUN Zheng-Hao, ZHOU Jia, TANG Juan, NI Jing

Author information +

History +

Abstract

Objective To investigate the application of endoscopic retrograde cholangiopancreatography (ERCP) in children and the risk factors for post-ERCP pancreatitis (PEP). Methods A retrospective analysis was conducted on the clinical data of 66 children, aged ≤16 years, who underwent ERCP for pancreaticobiliary diseases at the Gastrointestinal Endoscopy Center of the Second Affiliated Hospital of Kunming Medical University from September 2013 to September 2023. The incidence rate of PEP and the risk factors for the development of PEP were analyzed. Results A total of 78 ERCP procedures were performed on 66 children, with 5 diagnostic ERCPs, 69 therapeutic ERCPs, and 4 failed procedures. The success rate of ERCP operations was 95% (74/78). There were 17 cases of PEP in total, with an incidence rate of 22%. In the PEP group, the proportion of children with normal preoperative bilirubin and the proportion of guidewire insertion into the pancreatic duct during surgery were higher than in the non-PEP group (P<0.05). The multivariate logistic regression analysis showed that guidewire insertion into the pancreatic duct was an independent risk factor for PEP (P<0.05). Conclusions With the increasing application of ERCP in children with pancreaticobiliary diseases, it is important to select an appropriate intubation technique during surgery to avoid blindly entering the guidewire into the pancreatic duct and reduce the occurrence of PEP.

Key words

Endoscopic retrograde cholangiopancreatography / Pancreaticobiliary disease / Post-ERCP pancreatitis / Risk factor / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YANG Lu, FU Yan, SUN Zheng-Hao, ZHOU Jia, TANG Juan, NI Jing. Risk factors for pancreatitis after endoscopic retrograde cholangiopancreatography in children[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(7): 690-694 https://doi.org/10.7499/j.issn.1008-8830.2402047

References

1 McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of vater: a preliminary report[J]. Ann Surg, 1968, 167(5): 752-756. PMID: 5646296. PMCID: PMC1387128. DOI: 10.1097/00000658-196805000-00013.
2 Waye JD. Endoscopic retrograde cholangiopancreatography in the infant[J]. Am J Gastroenterol, 1976, 65(5): 461-463. PMID: 949055.
3 Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline[J]. Endoscopy, 2020, 52(2): 127-149. PMID: 31863440. DOI: 10.1055/a-1075-4080.
4 ?vitsland TL, Aabakken L. Endoscopic retrograde cholangiopancreatography in infants and children[J]. Endosc Int Open, 2021, 9(3): E292-E296. PMID: 33655024. PMCID: PMC7892276. DOI: 10.1055/a-1337-2212.
5 Perera KDR, Nawarathne NMM, Samarawickrama VT, et al. Endoscopic retrograde cholangiopancreatography in children: feasibility, success, and safety with standard adult endoscopes and accessories[J]. Pediatr Gastroenterol Hepatol Nutr, 2022, 25(5): 406-412. PMID: 36148288. PMCID: PMC9482827. DOI: 10.5223/pghn.2022.25.5.406.
6 Asenov Y, Ak?n M, Cantez S, et al. Endoscopic retrograde cholangiopancreatography in children: retrospective series with a long-term follow-up and literature review[J]. Turk J Gastroenterol, 2019, 30(2): 192-197. PMID: 30459128. PMCID: PMC6408168. DOI: 10.5152/tjg.2018.18165.
7 Mercier C, Pioche M, Albuisson E, et al. Safety of endoscopic retrograde cholangiopancreatography in the pediatric population: a multicenter study[J]. Endoscopy, 2021, 53(6): 586-594. PMID: 32599632. DOI: 10.1055/a-1209-0155.
8 Prasil P, Laberge JM, Barkun A, et al. Endoscopic retrograde cholangiopancreatography in children: a surgeon's perspective[J]. J Pediatr Surg, 2001, 36(5): 733-735. PMID: 11329577. DOI: 10.1053/jpsu.2001.22948.
9 Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: pathophysiology, early identification and risk stratification[J]. Adv Clin Exp Med, 2018, 27(1): 149-154. PMID: 29521055. DOI: 10.17219/acem/66773.
10 时秀梅, 彭海峰. 内镜逆行胰胆管造影术后胰腺炎的发病机制[J]. 内蒙古中医药, 2010, 29(18): 63-64. DOI: 10.3969/j.issn.1006-0979.2010.18.074.
11 Cahyadi O, Tehami N, de-Madaria E, et al. Post-ERCP pancreatitis: prevention, diagnosis and management[J]. Medicina (Kaunas), 2022, 58(9): 1261. PMID: 36143938. PMCID: PMC9502657. DOI: 10.3390/medicina58091261.
12 朱荣慧, 许业涛, 许金芳, 等. 放置胆管支架与儿童ERCP术后胰腺炎的关系[J]. 武警医学, 2022, 33(2): 98-101. DOI: 10.3969/j.issn.1004-3594.2022.02.002.
13 Troendle DM, Abraham O, Huang R, et al. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population[J]. Gastrointest Endosc, 2015, 81(6): 1408-1416. PMID: 25686874. DOI: 10.1016/j.gie.2014.11.022.
14 Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline—updated June 2014[J]. Endoscopy, 2014, 46(9): 799-815. PMID: 25148137. DOI: 10.1055/s-0034-1377875.
15 Martínez-Moneo E, Cárdenas-Jaén K, Fernández-Laso AB, et al. Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. Pancreatology, 2020, 20(5): 801-805. PMID: 32448748. DOI: 10.1016/j.pan.2020.05.002.
16 李媛媛, 李国华, 陈幼祥, 等. 导丝引导插管对ERCP术后胰腺炎的影响[J]. 南昌大学学报（医学版）, 2011, 51(10): 62-64. DOI: 10.3969/j.issn.1000-2294.2011.10.018.
17 秦学潜, 吴钢. 内窥镜下逆行胰胆管造影术中导丝进入胰管与术后高淀粉酶血症的相关性[J]. 安徽医药, 2020, 24(7): 1321-1324. DOI: 10.3969/j.issn.1009-6469.2020.07.013.
18 Palomera-Tejeda E, Shah MP, Attar BM, et al. Pharmacological and endoscopic interventions for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. Gastroenterology Res, 2023, 16(3): 149-156. PMID: 37351082. PMCID: PMC10284647. DOI: 10.14740/gr1620.